Generic Arimidex ( Anastrozole )

Arimidex

Arimidex (anastrozole) is a non‑steroidal aromatase inhibitor indicated for the adjuvant treatment of postmenopausal women with hormone receptor‑positive early breast cancer, for the first‑line treatment of postmenopausal women with hormone receptor‑positive or hormone receptor‑unknown locally advanced or metastatic breast cancer, and for advanced breast cancer in postmenopausal women with disease progression following tamoxifen therapy. Anastrozole works by selectively inhibiting the aromatase enzyme, which is responsible for converting androgens to estrogens in peripheral tissues. In postmenopausal women, this leads to a marked suppression of circulating estradiol levels, thereby reducing estrogen‑driven tumour growth. Arimidex is not effective in premenopausal women and should not be used in this population.

Usual adult dose: The recommended dose is 1 mg taken orally once daily, with or without food. Treatment is continued until disease progression or unacceptable toxicity in the metastatic setting; in the adjuvant setting, the optimal duration is generally 5 years, or as determined by the treating oncologist. No dose adjustment is required for elderly patients or for those with mild to moderate renal or hepatic impairment. In patients with severe hepatic impairment or severe renal impairment, use should be undertaken with caution. If a dose is missed, the patient should take the next dose at the usual time; two doses must not be taken on the same day. Arimidex should be swallowed whole with water.

Dosage form: Film‑coated tablets: 1 mg (white, round, biconvex, debossed with “A” on one side and “1” on the other). Available in blister packs or bottles of 30 tablets.

Onset of action: Estradiol levels are reduced by approximately 70% within 24 hours and by approximately 80% after 14 days of daily dosing. Steady‑state plasma concentrations of anastrozole are reached within about 7 days. Clinical benefit in breast cancer, such as tumour regression or delay in disease progression, is typically assessed after several weeks to months of continuous therapy.

Duration of action: The elimination half‑life of anastrozole is approximately 50 hours, supporting once‑daily dosing. Estrogen suppression persists throughout the dosing interval and is maintained with continuous daily therapy. After discontinuation, estradiol levels gradually return to baseline over several days.

Alcohol recommendation: No direct interaction between anastrozole and alcohol has been clearly established. However, excessive alcohol consumption may increase the risk of hot flashes, contribute to bone loss, and impair overall treatment tolerance. Patients should limit alcohol intake and discuss any concerns with their oncologist.

Most common side effects: Hot flashes, asthenia (weakness), arthralgia (joint pain), arthritis, bone pain, headache, nausea, and peripheral edema. Musculoskeletal symptoms are frequent and may require symptomatic management. Anastrozole reduces circulating estrogen and therefore causes loss of bone mineral density; osteoporosis and increased fracture risk are significant long‑term concerns. Bone density should be assessed at baseline and periodically, and calcium and vitamin D supplementation as well as bisphosphonates may be considered. Other effects include mood changes, depression, hypertension, and hypercholesterolemia. In women with pre‑existing ischemic heart disease, anastrozole has been associated with a slightly increased risk of cardiovascular events. Because Arimidex suppresses estrogen to near undetectable levels, it is not effective in premenopausal women; a reliable method of contraception is required in women of childbearing potential if used off‑label. Arimidex is available only by prescription and must be prescribed and monitored by a healthcare professional experienced in oncology.

Would you like to try Arimidex (Anastrozole) without a prescription?

Select doses
Select Package
Arimidex
1 mg
x
14 pills
$92.39
$ 76.99
$ 5.50 per pill
save:  $0.00
Arimidex
1 mg
x
28 pills
$123.59
$ 102.99
$ 3.68 per pill
save:  $50.96
Arimidex
1 mg
x
42 pills
$161.99
$ 134.99
$ 3.21 per pill
save:  $96.18
Arimidex
1 mg
x
56 pills
$184.79
$ 153.99
$ 2.75 per pill
save:  $154.00

Buy Generic Arimidex (Anastrozole) without prescription in Canada

At our pharmacy, you can buy Arimidex without a prescription, with discreet and anonymous packaging delivered within 5-14 days across Canada.

What is Arimidex?

Arimidex is a hormonal therapy used to treat certain types of breast cancer in postmenopausal women. The active ingredient is anastrozole, which belongs to a class of drugs called aromatase inhibitors. After menopause, the ovaries no longer produce estrogen. Instead, the body makes a small amount of estrogen from androgens through an enzyme called aromatase. That estrogen can fuel the growth of hormone receptor-positive breast cancer cells. Anastrozole blocks the aromatase enzyme, cutting off the last source of estrogen. The cancer cells starve, and the tumour stops growing or shrinks.

This is not chemotherapy. It's a daily pill that changes the body's hormone environment. The effect is measured over months, not days. Arimidex is used as adjuvant therapy after surgery to reduce the risk of recurrence, as first-line treatment for advanced or metastatic breast cancer, and sometimes after tamoxifen has stopped working. The standard dose is one 1 mg tablet taken once daily, every day, for years. It is not a drug you take for a short course. The full benefit accumulates over 5 years or more of continuous treatment. Arimidex is manufactured by AstraZeneca and is available as a generic under the name anastrozole.

Mechanism and Pharmacology

Anastrozole is a selective, non-steroidal aromatase inhibitor. It binds reversibly to the aromatase enzyme, which is responsible for converting androgens like androstenedione and testosterone into estrogens, specifically estrone and estradiol. In postmenopausal women, this peripheral conversion in fat, muscle, and liver tissue is the primary source of estrogen. By blocking the enzyme, anastrozole reduces blood estradiol levels by about 70 to 80 percent within a few days. In premenopausal women, the ovaries produce so much estrogen that this blockade is overwhelmed, which is why anastrozole is only used after menopause. In men, it is sometimes used off-label to manage estrogen excess from testosterone replacement therapy, but its official indication is breast cancer.

After oral administration, anastrozole is well absorbed, with peak plasma levels reached in about 2 hours. Food slightly reduces the rate of absorption but not the total amount, so it can be taken with or without food. The drug is extensively metabolized in the liver, primarily by CYP3A4, and the metabolites are excreted in urine. The half-life is about 50 hours, allowing for once-daily dosing. Steady-state levels are reached in about 7 days. Because estrogen is suppressed for the entire dosing interval, the anti-cancer effect is continuous. Liver function and kidney function do not require dose adjustment for mild to moderate impairment, but caution is advised in severe liver disease. Anastrozole does not significantly inhibit or induce cytochrome P450 enzymes at therapeutic doses, so it has relatively few drug interactions compared to many other cancer drugs.

How to Use Arimidex

Take one 1 mg tablet once daily, at the same time each day. You can take it with or without food. Swallow the tablet whole with water. Do not crush or chew it. The dose is always 1 mg daily for the approved indications; there is no dose titration. If you miss a dose, take it as soon as you remember, unless it is almost time for the next dose. In that case, skip the missed one and continue with your regular schedule. Do not double up. Missing an occasional dose is not usually dangerous, but consistency matters for long-term benefit.

Arimidex is usually taken for 5 years as adjuvant therapy, and sometimes longer. For metastatic breast cancer, it is continued as long as the cancer responds and side effects are manageable. Do not stop taking it without discussing with your oncologist. Stopping early reduces the benefit. Your doctor will monitor your bone density because long-term estrogen suppression weakens bones. You may need a bone density scan before starting and periodically during treatment. Calcium and vitamin D supplements are often recommended. If you develop joint pain or stiffness, tell your doctor. This is common and can usually be managed with exercise, analgesics, or sometimes a switch to a different aromatase inhibitor. Regular blood tests are not usually needed for anastrozole itself, but your doctor will monitor your overall health and may check your cholesterol, as estrogen suppression can raise lipid levels.

Side Effects of Arimidex

The side effects of anastrozole are largely the consequences of estrogen deprivation. The most common complaint is joint pain and stiffness. It can affect the hands, wrists, knees, and back, and for some women it is severe enough to make exercise difficult. The pain often improves over time, and regular physical activity, such as walking or swimming, helps. Acetaminophen or ibuprofen can be used, but check with your doctor. Some women find that switching to a different aromatase inhibitor, like letrozole or exemestane, relieves the joint pain. Hot flashes and night sweats are very common, because the body is being pushed into a deeper menopause. Dressing in layers, keeping the bedroom cool, and avoiding triggers like caffeine and alcohol can help. Vaginal dryness and decreased libido are also frequent. Water-based lubricants and vaginal moisturizers provide some relief. For women with severe vaginal symptoms, a low-dose topical estrogen may be considered, but this should be discussed with the oncologist, as even topical estrogen can be absorbed into the bloodstream.

Osteoporosis and bone fractures are a serious long-term risk. Anastrozole reduces bone density by lowering estrogen. Your doctor will monitor your bone density and may prescribe a bisphosphonate like alendronate or a newer agent like denosumab if your bones show significant thinning. Weight-bearing exercise, calcium, and vitamin D are essential. Fatigue is common and can be persistent. Some women also report mood changes, including mild depression or irritability. These usually settle over time. Hair thinning may occur, though it is usually mild. Anastrozole can raise cholesterol levels, so your lipid profile may be checked periodically. Rare but serious side effects include liver toxicity, presenting with jaundice or abdominal pain, and severe skin reactions. If you notice yellowing of your skin or eyes, stop the drug and call your doctor.

High-Risk Groups (Elderly, Pregnancy)

Pregnancy. Anastrozole is absolutely contraindicated during pregnancy. It can cause fetal harm and should never be used by a woman who is pregnant or may become pregnant. It is only indicated for postmenopausal women, so pregnancy is not usually a relevant concern. However, if a premenopausal woman somehow takes it, or if a postmenopausal woman becomes pregnant through assisted reproduction, the drug must be stopped immediately. Breastfeeding is not relevant for postmenopausal women, but anastrozole should not be used while breastfeeding. It may pass into breast milk and affect the infant.

Elderly women are the primary users of anastrozole, and the 1 mg dose is the same regardless of age. Older patients are more likely to have osteoporosis already, so bone density monitoring is especially important. They may also be more sensitive to joint pain and fatigue. No dose adjustment is needed for age alone. Patients with moderate to severe liver impairment should use anastrozole with caution, and liver function should be checked. Kidney impairment does not require a dose change. Women with severe osteoporosis or a history of fragility fractures should be started on bone-protective therapy early, as the drug will worsen bone loss. Those with a history of heart disease should be aware that aromatase inhibitors may slightly increase the risk of cardiovascular events, though the absolute risk is small. Regular monitoring of blood pressure and lipids is sensible.

Interaction With Activities (Driving, Alcohol)

Anastrozole does not cause drowsiness, dizziness, or cognitive impairment. You can drive and operate machinery normally. If you experience severe fatigue or joint pain that distracts you, use caution, but the drug itself does not affect alertness. Alcohol has no direct interaction with anastrozole. You can drink in moderation. However, alcohol can worsen hot flashes, disrupt sleep, and contribute to bone loss. It is best to keep alcohol intake light, especially if you are trying to manage side effects. Heavy drinking is discouraged, particularly if you have liver concerns or are taking other medications that affect the liver.

Drug Interactions

Anastrozole has relatively few significant drug interactions. It is metabolized by CYP3A4, but at therapeutic doses it does not substantially inhibit or induce any major drug-metabolizing enzymes. Tamoxifen, another hormonal therapy, should not be used together with anastrozole in the adjuvant setting. Tamoxifen can reduce the effectiveness of anastrozole when given simultaneously, and the combination offers no benefit over either drug alone. The two are used sequentially, not together. Estrogen-containing products, including hormone replacement therapy and some vaginal estrogen preparations, counteract the effect of anastrozole and should be avoided. If vaginal estrogen is needed, your oncologist will discuss the risks and benefits. Rifampin, a strong CYP3A4 inducer, can lower anastrozole levels, but the clinical significance is uncertain. No dose adjustment is usually made. Always tell your oncologist and pharmacist about every medication, supplement, and herbal product you take, including over-the-counter drugs. In particular, discuss any calcium, vitamin D, or bone-protective supplements you are using, as these are commonly recommended alongside anastrozole but should be part of a coordinated plan.

Alternative Options

Anastrozole is one of three aromatase inhibitors. Letrozole (Femara) and exemestane (Aromasin) are the other two. All three reduce estrogen to very low levels and are similarly effective, but they have slightly different side effect profiles. Some women who cannot tolerate the joint pain from anastrozole do better on letrozole or exemestane, and vice versa. Tamoxifen is a different kind of hormonal therapy. It blocks estrogen receptors rather than reducing estrogen production. Tamoxifen is still a standard option, especially in premenopausal women, and it has a different side effect profile, including a small risk of endometrial cancer and blood clots. For postmenopausal women, aromatase inhibitors are generally more effective than tamoxifen in reducing the risk of recurrence, but the choice depends on the individual woman's bone health, cardiovascular risk, and tolerance. For advanced breast cancer, fulvestrant is an injectable estrogen receptor antagonist used after aromatase inhibitors stop working. CDK4/6 inhibitors like palbociclib, ribociclib, and abemaciclib are often added to an aromatase inhibitor as first-line therapy for metastatic hormone receptor-positive breast cancer, and they significantly improve progression-free survival. Your oncologist will choose the best regimen based on your specific cancer characteristics and overall health.

INN, Brand Names, and Classification in Canada

INN (International Nonproprietary Name): Anastrozole
Available brand names in Canada: Arimidex, and generic anastrozole
ATC code: L02BG03
Forms and strengths: Film-coated tablets 1 mg. The standard dose is 1 mg once daily.
Manufacturers: AstraZeneca Canada Inc. (Arimidex), and diverse generic manufacturers including Apotex Inc., Teva Canada Limited, and Sandoz Canada Inc.
Registration status in Canada: Registered
Classification: Prescription (Rx)

Frequently Asked Questions

How long will I need to take Arimidex?
For adjuvant treatment after surgery, the usual duration is 5 years, and some women continue for up to 10 years based on their risk of recurrence. For metastatic breast cancer, it is taken as long as it keeps the cancer under control and side effects are tolerable. Your oncologist will tell you the expected duration for your situation.

Why does Arimidex cause joint pain?
Estrogen helps keep joints lubricated and reduces inflammation. When anastrozole lowers estrogen to near zero, many women feel stiffness and pain in their hands, knees, and back. The pain often improves over time. Staying active, stretching, and using mild pain relievers can help. If the pain is severe, your doctor may switch you to a different aromatase inhibitor.

Will I lose my hair?
Hair thinning is uncommon with anastrozole, but some women notice mild thinning or changes in hair texture. It is usually not the dramatic hair loss seen with chemotherapy. If it bothers you, talk to your doctor.

Can I take Arimidex with my calcium and vitamin D?
Yes. Calcium and vitamin D are often recommended to protect your bones while on anastrozole. Your doctor will tell you how much to take. If you are also prescribed a bisphosphonate or another bone-protective drug, follow the instructions for timing and how to take it.

What if I forget a dose?
Take it as soon as you remember, unless it is almost time for the next dose. If it is close to your next dose, skip the missed one. Do not take two tablets to catch up. An occasional missed dose will not ruin your treatment, but try to be consistent.

Delivery Information Across Canada

We ship Arimidex and generic anastrozole to all provinces and territories. Delivery times vary depending on how remote your location is:

  • Ontario (Toronto, Ottawa, Mississauga): 5 to 7 days
  • Quebec (Montreal, Quebec City, Laval): 5 to 7 days
  • British Columbia (Vancouver, Victoria, Burnaby): 5 to 9 days
  • Alberta (Calgary, Edmonton, Red Deer): 5 to 9 days
  • Manitoba (Winnipeg, Brandon): 5 to 9 days
  • Saskatchewan (Saskatoon, Regina): 5 to 9 days
  • Nova Scotia (Halifax, Sydney): 5 to 9 days
  • New Brunswick (Moncton, Fredericton): 5 to 9 days
  • Newfoundland and Labrador (St. John's, Corner Brook): 7 to 14 days
  • Prince Edward Island (Charlottetown): 7 to 14 days
  • Yukon, Northwest Territories, Nunavut: 7 to 14 days

All shipments are packed discreetly with no branding or indication of contents on the outside.

There is no review for this product at the moment, but you can be the first to add or you can read more in Testimonials Page about related products.
Package Example
Front View
Side View
Back View
Your order will be packed safe and secure and dispatched within 24 hours. This is exactly how your parcel will look like (pictures of a real shipping item). It has a size and a look of a regular private letter (9.4x4.3x0.3 inches or 24x11x0.7cm) and it does not disclose its contents
Shipping method Delivery time Price  
Delivery 14-21 days 14.95$ Tracking# available in 4 days
Delivery 9-14 days 30$ Tracking# available in 2 days
  • Shipping worldwide
  • Confidentiality and anonymity guarantee
  • Safe and secure
  • Discrete looking packages
  • Dispatch orders within 24 hours
  • 100% success delivery